Science Explorer Interactive view Map
Company · Watertown · United States

C4 Therapeutics (United States)

c4therapeutics.comROR OpenAlex
Research works
78
▲ 180% vs 2013–17
Citations
1.1k
14.6 per fractional work
Top-10% rate
19.6%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: C4 Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.48× its world share, 17 worksBiochemistry, Geneti…Immunology and Microbiology: 8.88× its world share, 4 worksImmunology and Micro…Neuroscience: 1.50× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.24× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.73× its world share, 0 worksChemical EngineeringChemistry: 0.61× its world share, 0 worksChemistryEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.77× its world share, 1 worksMaterials ScienceMathematics: 0.65× its world share, 0 worksMathematicsMedicine: 2.19× its world share, 18 worksMedicineNursing: 0.49× its world share, 0 worksNursingBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Social Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.

Which keywords describe research at C4 Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Tumor Microenvironment, Proteasome Inhibitors, Transcriptional Regulation, Cancer Immunotherapy, Innate Immunity and BET Bromodomains.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy5▲ 19×11 topics
  2. Cancer5▲ 8.0×14 topics
  3. Tumor Microenvironment4▲ 22×7 topics
  4. Inflammation3▲ 3.7×10 topics
  5. Proteasome Inhibitors3▲ 109×2 topics
  6. Transcriptional Regulation3▲ 42×5 topics
  7. Cancer Immunotherapy3▲ 42×2 topics
  8. Innate Immunity3▲ 19×5 topics
  9. BET Bromodomains2▲ 204×1 topic
  10. Immunotherapy2▲ 8.1×5 topics
  11. PROTACs2▲ 204×1 topic
  12. Tumor Regression2▲ 51×2 topics
  13. Gene Therapy2▲ 25×3 topics
  14. Proteasome2▲ 139×1 topic
  15. Ubiquitin2▲ 139×1 topic
  16. Immune Checkpoint Blockade2▲ 41×1 topic
  17. PD-1 and PD-L12▲ 41×1 topic
  18. Lymphoma2▲ 26×2 topics
  19. CAR T Cells2▲ 55×1 topic
  20. Cancer Progression2▲ 22×4 topics
  21. Chimeric Antigen Receptor2▲ 55×1 topic
  22. Immune Response2▲ 6.9×4 topics
  23. Immunity2▲ 9.1×5 topics
  24. Genomic Analysis1▲ 13×3 topics
  25. Fc Receptors1▲ 56×1 topic
  26. Therapeutic Antibodies1▲ 44×1 topic
  27. Antigen Presentation1▲ 32×2 topics
  28. Diagnosis Criteria1▲ 79×1 topic
  29. International Myeloma Working Group1▲ 79×1 topic
  30. Minimal Residual Disease1▲ 42×2 topics
  31. Neurodegeneration1▲ 9.2×6 topics
  32. RNA methylation1▲ 31×1 topic
  33. m6A-seq1▲ 31×1 topic
  34. Dendritic Cells1▲ 27×1 topic
  35. Drug Discovery1▲ 11×5 topics
  36. Hematopoietic Stem Cells1▲ 29×3 topics
  37. IL-61▲ 119×1 topic
  38. Mutation1▲ 14×5 topics
  39. STAT31▲ 119×1 topic
  40. Tumor Antigen1▲ 40×1 topic

Which research topics does C4 Therapeutics (United States) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Protein Degradation and …2Protein Degradation and Inhibitors: 2 fractional worksUbiquitin and proteasome…2Ubiquitin and proteasome pathways: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksRNA modifications and cancer: 1 fractional worksMultiple Myeloma Researc…1Multiple Myeloma Research and Treatments: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCytokine Signaling Pathw…1Cytokine Signaling Pathways and Interactions: 1 fractional worksTraditional Chinese Medi…1Traditional Chinese Medicine Studies: 1 fractional works
Molecular BiologyOncologyRadiology, Nuclear Medicine and ImagingHematology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 2 works
  2. 2 Ubiquitin and proteasome pathways Molecular Biology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 RNA modifications and cancer Molecular Biology 1 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 1 works
  8. 8 Immunotherapy and Immune Responses Immunology 1 works
  9. 9 Cytokine Signaling Pathways and Interactions Oncology 1 works
  10. 10 Traditional Chinese Medicine Studies Complementary and alternative medicine 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.2%not open50.8%

World: 28% of research is openly available.

with international co-authors19.7%domestic only80.3%

World: 19% is written across borders.

How has C4 Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 180% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Watertown

All research institutions in Watertown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.